Darrel P. Cohen

1.7k total citations · 1 hit paper
31 papers, 1.2k citations indexed

About

Darrel P. Cohen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Darrel P. Cohen has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Darrel P. Cohen's work include Gastrointestinal Tumor Research and Treatment (7 papers), Renal cell carcinoma treatment (6 papers) and Gastric Cancer Management and Outcomes (6 papers). Darrel P. Cohen is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (7 papers), Renal cell carcinoma treatment (6 papers) and Gastric Cancer Management and Outcomes (6 papers). Darrel P. Cohen collaborates with scholars based in United States, Canada and France. Darrel P. Cohen's co-authors include George D. Demetri, Christopher L. Corless, Robert G. Maki, Charles M. Baum, Cristina R. Antonescu, Christopher D.�M. Fletcher, Xin Huang, Jonathan A. Fletcher, Michael C. Heinrich and Arin McKinley and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Darrel P. Cohen

31 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

2008 564 citations Michael C. Heinrich, Robert G. Maki et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Darrel P. Cohen

Since Specialization

Citations

This map shows the geographic impact of Darrel P. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darrel P. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darrel P. Cohen more than expected).

Fields of papers citing papers by Darrel P. Cohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darrel P. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darrel P. Cohen. The network helps show where Darrel P. Cohen may publish in the future.

Co-authorship network of co-authors of Darrel P. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Darrel P. Cohen. A scholar is included among the top collaborators of Darrel P. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darrel P. Cohen. Darrel P. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients 2015 ·British Journal of Cancer ·Frede Donskov, M. Dror Michaelson, Igor Puzanov, Mellar P. Davis, Georg A. Bjarnason, Robert J. Motzer, David Goldstein, Xun Lin, Darrel P. Cohen, Robin Wiltshire, Brian I. Rini	76
2	Complete Longitudinal Analyses of the Randomized, Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib Failure 2012 ·Clinical Cancer Research ·George D. Demetri, (unknown), Patrick Schöffski, Manisha H. Shah, Jaap Verweij, Serge Leyvraz, Herbert I. Hurwitz, Antonio López–Pousa, Axel Le Cesne, David S. Goldstein, Luis Paz‐Ares, Jean‐Yves Blay, Grant A. McArthur, Qiang Xu, Xin Huang, Charles S. Harmon, Vanessa Tassell, Darrel P. Cohen, Paolo G. Casali	102
3	Comparative Assessment of Sunitinib-Associated Adverse Events (AES) as Potential Biomarkers of Efficacy in Metastatic Renal Cell Carcinoma (MRCC) 2012 ·Annals of Oncology ·Frede Donskov, M. Dror Michaelson, Igor Puzanov, Mellar P. Davis, Georg A. Bjarnason, Robert J. Motzer, Xun Lin, Darrel P. Cohen, Robin Wiltshire, Brian I. Rini	11
4	Hypertension as a potential biomarker of efficacy in patients with gastrointestinal stromal tumor treated with sunitinib 2012 ·Annals of Oncology ·Suzanne George, Peter Reichardt, (unknown), (unknown), Darrel P. Cohen, George D. Demetri	75
5	Evaluation of hand-foot syndrome (HFS) as a potential biomarker of sunitinib (SU) efficacy in patients (pts) with metastatic renal cell carcinoma (mRCC) and gastrointestinal stromal tumor (GIST). 2011 ·Journal of Clinical Oncology ·Igor Puzanov, M. Dror Michaelson, Darrel P. Cohen, (unknown), Patrick Burnett, Jayesh Desai	14
6	747 PHARMACOKINETICS OF THE HCV POLYMERASE INHIBITOR ABT-072 FOLLOWING SINGLE AND MULTIPLE DOSING IN HEALTHY ADULT VOLUNTEERS 2010 ·Journal of Hepatology ·Emily O. Dumas, Walid M. Awni, Darrel P. Cohen, Barry Bernstein, Aly Nada, Yi‐Lin Chiu, Catherine Klein	2
7	Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure 2009 ·Clinical Cancer Research ·George D. Demetri, Michael C. Heinrich, Jonathan A. Fletcher, Christopher D.�M. Fletcher, Annick D. Van den Abbeele, Christopher L. Corless, Cristina R. Antonescu, Suzanne George, Jeffrey A. Morgan, Ming Hui Chen, Carlo L. Bello, Xin Huang, Darrel P. Cohen, Charles M. Baum, Robert G. Maki	104
8	Sunitinib and PF-562,271 (FAK/Pyk2 inhibitor) effectively block growth and recovery of human hepatocellular carcinoma in a rat xenograft model 2009 ·Cancer Biology & Therapy ·Cedo M. Bagi, James R. Christensen, Darrel P. Cohen, W. Gregory Roberts, Dean Wilkie, Terri A. Swanson, Theresa Tuthill, Catharine J. Andresen	62
9	Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor breakdown → 2008 ·Journal of Clinical Oncology ·Michael C. Heinrich, Robert G. Maki, Christopher L. Corless, Cristina R. Antonescu, Amy Harlow, Diana Griffith, Ajia Town, Arin McKinley, Wen‐Bin Ou, Jonathan A. Fletcher, Christopher D.�M. Fletcher, Xin Huang, Darrel P. Cohen, Charles M. Baum, George D. Demetri	564
10	Comparative efficacy of sunitinib administered on an intermittent or a continuous daily dosing schedule in metastatic renal cell carcinoma (mRCC) and gastrointestinal stromal tumor (GIST) patients predicted using population PK approaches 2008 ·Cancer Research ·Brett E. Houk, Carlo L. Bello, George D. Demetri, M. Dror Michaelson, Paolo G. Casali, Ronald M. Bukowski, Darrel P. Cohen, Kuniaki Shirao, Bruce G. Redman, Gary R. Hudes, George Wilding, Robert J. Motzer	4
11	A Phase I Study of UFT/Leucovorin, Carboplatin, and Paclitaxel in Combination With External Beam Radiation Therapy for Advanced Esophageal Carcinoma 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Brian G. Czito, Darrel P. Cohen, Chris R. Kelsey, A. Craig Lockhart, Johanna C. Bendell, Christopher G. Willett, William P. Petros, Thomas A. D’Amico, (unknown), Herbert I. Hurwitz	1
12	Efficacy of sunitinib in patients with gastrointestinal stromal tumor (GIST): an exposure-response based meta-analysis 2007 ·Brett E. Houk, Carlo L. Bello, Darrel P. Cohen, George D. Demetri, Paolo G. Casali, Kuniaki Shirao	2
13	Safety and pharmacokinetics of intravenous VEGF Trap plus FOLFOX4 in a combination phase I clinical trial of patients with advanced solid tumors 2006 ·Journal of Clinical Oncology ·Marilyn Mulay, Steven Limentani, (unknown), Eric S. Furfine, Darrel P. Cohen, Lee S. Rosen	12
14	A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon 2004 ·International Journal of Radiation OncologyBiologyPhysics ·Brian G. Czito, Timothy Hong, Darrel P. Cohen, Douglas S. Tyler, (unknown), Mitchell S. Anscher, Kirk Ludwig, Hilliard F. Seigler, Christopher R. Mantyh, Michael A. Morse, A. Craig Lockhart, William P. Petros, Wanda Honeycutt, Neil L. Spector, (unknown), (unknown), Herbert I. Hurwitz	6
15	Pharmacokinetics and bioequivalence of a combined oral formulation of eniluracil, an inactivator of dihydropyrimidine dehydrogenase, and 5-fluorouracil in patients with advanced solid malignancies 2000 ·Annals of Oncology ·(unknown), Herbert I. Hurwitz, George Wilding, Darrel P. Cohen, (unknown), Garry Schwartz, (unknown), William P. Petros, (unknown), (unknown), (unknown), Ronald Drengler, (unknown), Eric K. Rowinsky	12
16	Pre-clinical evaluation of SN-38 and novel camptothecin analogs against human chronic B-cell lymphocytic leukemia lymphocytes 1999 ·Leukemia Research ·Darrel P. Cohen, David J. Adams, James L. Flowers, Monroe E. Wall, Mansukh C. Wani, Govindarajan Manikumar, O. Michael Colvin, Robert Silber	11
17	Iodocalcitonin binds to human calcitonin receptors with higher affinity than calcitonin. 1996 ·Endocrinology ·Darrel P. Cohen, Daniel R. Nussenzveig, M C Gershengorn	3
18	CD5‐like Phorbol‐Ester Responsiveness in Conventional B Cells Activated through Surface Immunoglobulin^a 1992 ·Annals of the New York Academy of Sciences ·Thomas L. Rothstein, (unknown), Darrel P. Cohen	1
19	Induction of Suppressor Cell Activity by Cyclosporin A and/or Uremic Serum in Normal versus Uremic Peripheral Blood Mononuclear Cells 1990 ·International Archives of Allergy and Immunology ·David Modai, Sylvia Berman, Darrel P. Cohen, M Amit, M. Cohn, Joshua Weissgarten, Zhan Averbukh	1
20	Adenosine 3′,5′-cyclic monophosphate modulates the mitogenic responses of murine B lymphocytes 1989 ·Cellular Immunology ·Darrel P. Cohen, Thomas L. Rothstein	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact